临床病理特征 | 例数(n) | miRNA-181表达水平 | P值 | PTEN蛋白阳性表达率 | P值 |
性别 |
|
|
|
|
|
男 | 36 | 7.18 ± 2.24 |
| 30% |
|
女 | 24 | 6.84 ± 2.18 | 0.681 | 32% | 0.734 |
年龄 |
|
|
|
|
|
<40岁 | 8 | 6.94 ± 2.19 |
| 36% |
|
41~59岁 | 35 | 7.13 ± 2.25 |
| 35% |
|
>60岁 | 17 | 7.22 ± 2.36 | 0.258 | 30% | 0.695 |
临床TNM分期 |
|
|
|
|
|
I期 | 4 | 2.26 ± 1.09 |
| 43% |
|
II期 | 8 | 3.17 ± 1.83 |
| 37% |
|
III期 | 28 | 5.04 ± 2.06 |
| 18% |
|
IV期 | 20 | 7.38 ± 2.45 | 0.012 | 11% | 0.001 |
淋巴结转移 |
|
|
|
|
|
有 | 46 | 7.66 ± 2.63 |
| 15% |
|
无 | 14 | 2.89 ± 1.06 | 0.011 | 46% | 0.001 |
病理分级 |
|
|
|
|
|
未 + 低分化 | 28 | 7.88 ± 2.71 |
| 12% |
|
中 + 高分化 | 32 | 2.67 ± 1.04 | 0.009 | 45% | 0.000 |